Amendment No. 2.pdf
PDF 93 KB Posted
- Attached to
- Early Phase Clinical Trial Units (EPCTU)
- Solicitation number
- RFP-NIAID-NIH-AI-75N93020R00023
About this file
This amendment modifies a solicitation for Early Phase Clinical Trial Units. The National Institute of Allergy and Infectious Diseases is seeking clinical trial units to conduct early phase clinical trials of vaccines, therapeutics, and other medical products to address emerging and re-emerging infectious diseases. Amendment 2 provides clarification to responses received regarding questions on the solicitation and does not otherwise alter the terms and conditions. The point of contact for any questions is the contracting officer via the provided email address. The deadline for acknowledgement of amendment receipt is prior to the hour and date specified for receipt of offers.
View the file
Other files
Show all 17
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
AMENDMENT OF SOLICITATION
Solicitation Number: NIAID-NIH-AI-75N93020R00023 Amendment Number: 2
AMENDMENT TWO (2)
Issued by: National Institute of Allergy and Infectious Diseases (NIAID)
Office of Acquisitions, MSC 9821 5601 Fishers Lane Rockville, MD 20852
Solicitation Number: NIAID-NIH-AI-75N93020R00023
Date of Solicitation Issuance: November 30, 2020
Date of Amendment No.2 Issuance: March 2, 2021
Number of Pages: 6 Pages
NIAID Point of Contact: PRIMARY:
Michael P. Welsh, Contracting Officer Email: welshmi@niaid.nih.gov Phone: 240-669-5132
Offerors MUST acknowledge receipt of this amendment, by Amendment number(s) and date of the amendment.
FAILURE OF YOUR ACKNOWLEDEMENT AT THE PLACE DESIGNATED FOR THE
RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT
IN REJECTION OF YOUR OFFER.
Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.
Purpose of Solicitation Amendment:
The purpose of Amendment No. 2 is to clarify some of the responses to questions received regarding the solicitation.
mailto:welshmi@niaid.nih.gov
ALL OTHER TERMS AND CONDITIONS OF THE SOLICITATION REMAIN
UNCHANGED.
End of Amendment 2
File details come from the government source that posted it. Updated .